본문 바로가기

Hwangryunhaedoktang in adult patients with Atopic Dermatitis: a randomised, double-blind, placebo-controlled, two-centre trial - study protocol

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
피인용
Web of Science 16
JCR IF
JCR 2010 2.195
ISSN
1472-6882

저자

  1. 김남권제1저자교신저자Opthalmology Otolaryngology and Dermatology, Wonkwang Univ. Sanbon Oriental Medical Center, South Korea
  2. Lee, Dong-HyoOpthalmology Otolaryngology and Dermatology, Wonkwang Univ. Sanbon Oriental Medical Center, South Korea
  3. 서형식Opthalmology Otolaryngology and Dermatology, Pusan National Univ. School of Korean Medicine, South Korea
  4. Sun, Seung-HoInternal Medicine, Sangji Univ. Oriental Medical Center, South Korea
  5. Oh, Yong-LeolGastroenterology, Wonkwang Univ. Sanbon Medical Center, South Korea
  6. Kim, Ji-EunOpthalmology Otolaryngology and Dermatology, Sangji Univ. Oriental Medical Center, South Korea
  7. Yoon, In-HwanOpthalmology Otolaryngology and Dermatology, Wonkwang Univ. Sanbon Oriental Medical Center, South Korea
  8. Seo, Eun-SungDepartment of Oriental Medicine, Graduate School of Wonkwang University, South Korea
  9. Shim, Gye-SeonOpthalmology Otolaryngology and Dermatology, Wonkwang Univ. Sanbon Oriental Medical Center, South Korea
  10. Zaslawski, ChristopherCollege of Traditional Chinese Medicine, Department of Medical and Molecular Biosciences, Faculty of Science, University of Technology, Australia

초록

Background: Atopic Dermatitis is a chronic relapsing eczematous skin disease with increasing prevalence and rising costs. It has a clear impact on a patient's quality of life. Many patients are worried about the use of usual care techniques, such as corticosteroids and antihistamine due to the widespread fear of adverse effects. Complementary and alternative medical approaches have been employed to relieve symptoms of Atopic Dermatitis. Hwangryunhaedoktang is among the most strongly preferred and widely used herbal medicines for Atopic Dermatitis in Korea, as it causes very few serious adverse effects. We aim to establish basic clinical efficacy and safety data for Hwangryunhaedoktang, which is approved as an herbal medication by the Korean Food and Drug Administration, in adult patients with Atopic Dermatitis. Methods/Designs: This study is a randomised, double blind, placebo-controlled, two-centre trial with two parallel arms (Hwangryunhaedoktang and a placebo). The diagnosis of Atopic Dermatitis will be made according to the criteria of Hanifin and Rajka by two different Oriental medicine doctors. We will include participants experiencing typical conditions of intermittent or continuous Atopic Eczema for six or more months. Participants will receive Hwangryunhaedoktang or a placebo-drug for eight weeks. The total duration of each arm is eleven weeks. Each participant will be examined for signs and symptoms of Atopic Dermatitis before and after taking medication. A follow-up to evaluate the maintenance of safety will be performed two weeks after the final administration of medication. Discussion: This trial will utilize high quality trial methodologies in accordance with consolidated standards of reporting trials guidelines. It will provide evidence for the clinical efficacy and safety evaluation of Hwangryunhaedoktang in adult patients with Atopic Dermatitis. Moreover, we will also employ health-related quality of life questionnaires to assess the changes in quality of life.

키워드

CHINESE HERBAL MEDICINEEPIDEMIOLOGYACUPUNCTUREDIAGNOSISEFFICACYCHILDRENECZEMA

식별자

WoS UID
000295263100001